Cargando…
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
BACKGROUND: Prolactinoma is the major cause of hyperprolactinemia, and dopamine agonists (DAs) are generally the first-line treatment for them. Several studies have reviewed the recurrent rate of hyperprolactinemia after DAs withdrawal. However, few of them have concerned the recurrence risk of prol...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590353/ https://www.ncbi.nlm.nih.gov/pubmed/34774043 http://dx.doi.org/10.1186/s12902-021-00889-1 |